M. A. N. Sendur Et Al. , "Does trastuzumab-emtansine have better cardiac safety profile in contrast to trastuzumab?," JOURNAL OF BUON , vol.18, no.3, pp.801, 2013
Sendur, M. A. N. Et Al. 2013. Does trastuzumab-emtansine have better cardiac safety profile in contrast to trastuzumab?. JOURNAL OF BUON , vol.18, no.3 , 801.
Sendur, M. A. N., Aksoy, S., Ozdemir, Y., Zengin, N., & Altundag, K., (2013). Does trastuzumab-emtansine have better cardiac safety profile in contrast to trastuzumab?. JOURNAL OF BUON , vol.18, no.3, 801.
Sendur, M. Et Al. "Does trastuzumab-emtansine have better cardiac safety profile in contrast to trastuzumab?," JOURNAL OF BUON , vol.18, no.3, 801, 2013
Sendur, M. A. Et Al. "Does trastuzumab-emtansine have better cardiac safety profile in contrast to trastuzumab?." JOURNAL OF BUON , vol.18, no.3, pp.801, 2013
Sendur, M. A. N. Et Al. (2013) . "Does trastuzumab-emtansine have better cardiac safety profile in contrast to trastuzumab?." JOURNAL OF BUON , vol.18, no.3, p.801.
@article{article, author={M. A. N. Sendur Et Al. }, title={Does trastuzumab-emtansine have better cardiac safety profile in contrast to trastuzumab?}, journal={JOURNAL OF BUON}, year=2013, pages={801} }